Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer

Guru Sonpavde; Matthew D. Galsky; David Latini; Guoqing J. Chen

doi:10.1016/j.clgc.2013.11.016

Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer

Guru Sonpavde
, Matthew D. Galsky
, David Latini
, Guoqing J. Chen

Research output: Contribution to journal › Comment/debate

45 Scopus citations

Original language	English
Pages (from-to)	71-73
Number of pages	3
Journal	Clinical Genitourinary Cancer
Volume	12
Issue number	2
DOIs	https://doi.org/10.1016/j.clgc.2013.11.016
State	Published - Apr 2014
Externally published	Yes

Access to Document

10.1016/j.clgc.2013.11.016

Cite this

@article{f220868b947447e0950f0d3668cc2721,

title = "Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer",

author = "Guru Sonpavde and Galsky, \{Matthew D.\} and David Latini and Chen, \{Guoqing J.\}",

year = "2014",

month = apr,

doi = "10.1016/j.clgc.2013.11.016",

language = "English",

volume = "12",

pages = "71--73",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer

AU - Sonpavde, Guru

AU - Galsky, Matthew D.

AU - Latini, David

AU - Chen, Guoqing J.

PY - 2014/4

Y1 - 2014/4

UR - https://www.scopus.com/pages/publications/84896405606

U2 - 10.1016/j.clgc.2013.11.016

DO - 10.1016/j.clgc.2013.11.016

M3 - Comment/debate

C2 - 24355418

AN - SCOPUS:84896405606

SN - 1558-7673

VL - 12

SP - 71

EP - 73

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 2

ER -